The Proof with Simon Hill cover image

Hunger, weight loss and obesity | Stephan Guyenet, PhD

The Proof with Simon Hill

00:00

The Benefits of GLP1 Agonists for Obesity

Semaglutide and GLP1 agonists are becoming more popular with regards to treatment of obesity. They're a gut hormone that's produced by primarily the small intestine. It increases insulin secretion to help cover the glucose that you ate in your meal. And it also signals to the brain to increase satiety or fullness. So they just are much more effective than anything that came before them, more effective and more safe.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app